Tania Phillips Selected Research

5-alpha Reductase Inhibitors

3/2004

A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tania Phillips Research Topics

Disease

5	Wounds and Injuries (Trauma) 01/2016 - 07/2006
2	Leg Ulcer 05/2009 - 09/2002
1	Infections 01/2016
1	Surgical Wound 05/2009
1	Ulcer 05/2009
1	Diabetic Foot 05/2009
1	Hyperpigmentation 01/2005
1	Lentigo (Lentiginosis) 01/2005
1	Acne Vulgaris 03/2004
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2003

Drug/Important Bio-Agent (IBA)

1	Anti-Infective Agents (Microbicides)IBA 01/2016
1	ElementsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	ApligrafIBA 07/2006
1	Polyurethanes (Polyurethane)IBA 07/2006
1	DNA (Deoxyribonucleic Acid)IBA 07/2006
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2005
1	5-alpha Reductase InhibitorsIBA 03/2004
1	Minocycline (Cyclops)FDA LinkGeneric 03/2004
1	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)IBA 03/2004
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2003

Therapy/Procedure

2	Debridement 05/2009 - 11/2006
1	Therapeutics 09/2002